PHI with Chronic nephritis
How does this condition affect your private health insurance?
Chronic nephritis encompasses a spectrum of kidney disorders marked by persistent inflammation of the glomeruli, the vital filtering units within the kidneys. This sustained inflammatory process, often triggered by autoimmune conditions, infections, or genetic factors, progressively damages renal tissue. Over time, the kidneys' capacity to efficiently filter waste products from the blood diminishes, leading to a gradual decline in kidney function. Symptoms, including fatigue, swelling, and hypertension, typically emerge subtly. If left unmanaged, chronic nephritis can advance to end-stage renal disease, necessitating dialysis or kidney transplantation. Treatment focuses on mitigating progression and alleviating symptoms.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Gradual onset, developing insidiously over months to years, often with subtle or non-specific symptoms.
Duration of Illness (Lifetime)
Chronic, lifelong condition, often progressive, requiring continuous management.
Cost of Treatment (Initial)
Moderate to high, involving diagnostic tests (blood, urine, biopsy), specialist consultations, and initial medication regimens.
Cost of Treatment (Lifetime)
Very high, due to ongoing medication, regular specialist visits, monitoring of kidney function, management of complications, and potential for dialysis or kidney transplantation.
Mortality Rate
Moderate to high over a lifetime, particularly if it progresses to end-stage renal disease and associated cardiovascular complications.
Risk of Secondary Damages
High, including hypertension, anemia, bone disease, cardiovascular disease, neuropathy, and eventual end-stage renal disease.
Probability of Full Recovery
Low to very low, as chronic implies persistent and often irreversible damage; management focuses on slowing progression rather than complete cure.
Underlying Disease Risk
Moderate to high, often associated with autoimmune diseases (e.g., lupus), systemic infections, diabetes, vasculitis, or genetic predispositions.